Search Results - "TROMM, Andreas"
-
1
Necessary additional points
Published in Deutsches Ärzteblatt international (21-03-2014)Get full text
Journal Article -
2
Correspondence (letter to the editor): Necessary Additional Points
Published in Deutsches Ärzteblatt international (01-03-2014)Get full text
Journal Article -
3
Necessary Additional Points
Published in Deutsches Ärzteblatt international (21-03-2014)Get full text
Journal Article -
4
Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease
Published in Gastroenterology (New York, N.Y. 1943) (01-02-2011)“…Background & Aims Comparative data on budesonide vs mesalamine for the treatment of mild-to-moderately active Crohn's disease (CD) are sparse. We assessed the…”
Get full text
Journal Article -
5
-
6
Cholesteryl Ester Storage Disease: Fatal Outcome without Causal Therapy in a Female Patient with the Preventable Sequelae of Progressive Liver Disease after Many Years of Mild Symptoms
Published in The American journal of case reports (18-05-2018)“…BACKGROUND Cholesteryl ester storage disease (CESD), also known as lysosomal acid lipase deficiency (LAL-D), is a rare autosomal-recessive inheritable…”
Get full text
Journal Article -
7
Budesonide treatment for collagenous colitis: A randomized, double-blind, placebo-controlled, multicenter trial
Published in Gastroenterology (New York, N.Y. 1943) (01-10-2002)“…Background & Aims: Collagenous colitis is an idiopathic microscopic colitis characterized by chronic watery diarrhea, a typical subepithelial collagen layer,…”
Get full text
Journal Article -
8
A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene
Published in International journal of colorectal disease (01-03-2004)“…Nuclear factor kappa-B (NFkappaB) plays a crucial role in diseases associated with dysregulated immune response. NFkappaB inhibitor alpha downregulates the…”
Get full text
Journal Article -
9
391 Both Budesonide (9mg) As Well As High-Dose Eudragit-L-Coated Mesalamine (4.5g) Lead to High Remission Rates in Moderately Active Crohn's Disease Patients: A Double-Blind, Double-Dummy, Randomized, Multicenter Study
Published in Gastroenterology (New York, N.Y. 1943) (2009)Get full text
Journal Article -
10
Collagenous colitis: implications for the role of vascular endothelial growth factor in repair mechanisms
Published in European journal of gastroenterology & hepatology (01-04-2004)“…OBJECTIVESCollagenous colitis is a chronic inflammatory bowel disease with a band-like subepithelial deposition of immature extracellular matrix. Because the…”
Get full text
Journal Article -
11
A polymorphism of the bactericidal/permeability increasing protein (BPI) gene is associated with Crohn's disease
Published in Journal of clinical gastroenterology (01-04-2005)“…The bactericidal/permeability increasing protein (BPI) is involved in the elimination of gram-negative bacteria. A functionally relevant single nucleotide…”
Get full text
Journal Article -
12
Collagenous colitis: Implications for the role of vascular endothelial growth factor in repair mechanisms
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2003)Get full text
Journal Article -
13
The IL-10 gene is not involved in the predisposition to inflammatory bowel disease
Published in Electrophoresis (01-11-2000)“…Although genetic predisposition for inflammatory bowel disease (IBD) is well established, little is known about the accountable genes. The pathogenesis of IBD…”
Get full text
Journal Article -
14
Vascular endothelial growth factor (VEGF) in Crohn's disease : Increased production by peripheral blood mononuclear cells and decreased VEGF165 labeling of peripheral CD14+ monocytes
Published in Digestive diseases and sciences (01-06-1999)“…Recently, increased serum levels of vascular endothelial growth factor (VEGF) have been shown in patients with inflammatory bowel disease. The origins of the…”
Get full text
Journal Article -
15
Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties
Published in Hepato-gastroenterology (01-11-1999)“…The release of 5-ASA from various preparations depends on the presence of bacterial azoreductases (sulphasalazine, olsalazine, balsalazide) or the…”
Get more information
Journal Article -
16
Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid
Published in Hepato-gastroenterology (01-05-2005)“…We report about a 56-year-old asymptomatic female patient, who was examined in April 1991 for an increase of biochemical parameters of the liver. Based on the…”
Get more information
Journal Article -
17
The polymorphism at position - 174 of the IL-6 gene is not associated with inflammatory bowel disease
Published in European journal of gastroenterology & hepatology (2001)“…Inflammatory bowel diseases (IBD) are multifactorial disorders, characterized by failure to limit the inflammatory response to luminal antigens. Genetic…”
Get full text
Journal Article -
18
Vascular endothelial growth factor (VEGF) in Crohn's disease: Increased production by peripheral blood mononuclear cells and decreased VEGF^sub 165^ labeling of peripheral CD14 ^sup +^ monocytes
Published in Digestive diseases and sciences (01-06-1999)“…Recently, increased serum levels of vascular endothelial growth factor (VEGF) have been shown in patients with inflammatory bowel disease. The origins of the…”
Get full text
Journal Article -
19
-
20
Gastric emptying of fluids by antrumplanimetry in healthy volunteers: age-(in-)dependent?
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2000)Get full text
Journal Article